1 – 10 of 86
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
- Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect
- Stromal protein expression in breast cancer is differentially regulated by TGF-β1
- EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
- 2014
- A breath test for diagnosing malignant pleural mesothelioma
- Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model: a study based on data from an international multicentre project (EPCRC-CSA)
- Hypofractionated radiotherapy reduces acute skin toxicity in small and large breasted patients receiving whole-breast irradiation
- Stromal characteristics are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ (DCIS)
- Budget impact vs cost effectiveness: implications for personalised cancer therapies
- 2013
- Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digstive Oncology
- A phase Ib, open-label study to assess the safety of continuous oral treatment with afatinib in combination with two chemotherapy regimens: cisplatin plus paclitaxel and cisplatin plus 5-fluorouracil, in patients with advanced solid tumors